Florida State flag

An official website of the Florida State government.

Drug Criteria

Drug Criteria

Abecma Criteria [ pdf 119.2 kB ] Added 5/7/2021

Abilify Mycite Criteria [ pdf 125.6 kB ] Updated 7/18/2023

Abstral/Actiq/Fentora/Lazanda/Onsolis/Subsys Criteria [ pdf 333.5 kB ] Updated 03/2018

Abstral/Actiq/Fentora/Lazanda/Onsolis/Subsys PA Form [ pdf 1001.5 kB ] Updated 11/28/2023

Adakveo Criteria [ pdf 74.6 kB ] Updated 1/24/2024

Adbry Criteria [ pdf 125.1 kB ] Updated 2/8/2024

Adlarity Criteria [ pdf 113.4 kB ]  Added 11/15/2022

Aduhelm Criteria [ pdf 198.3 kB ] Updated 10/2/2023

Adult High Dose Antipsychotic Criteria [ pdf 134.1 kB ] Updated 1/24/2024

Adult High Dose Antipsychotic PA Form [ pdf 545.7 kB ] Updated 11/28/2023

Adzynma Criteria [ pdf 208.4 kB ] Updated 3/11/2024

Aemcolo Criteria [ pdf 150.6 kB ] Added 3/13/2023

Afrezza Criteria [ pdf 183.1 kB ] Updated10/2/2023

Agamree Criteria [ pdf 115.1 kB ] Added 7/1/2024

Albumin PA Form [ pdf 968.7 kB ] Updated 11/28/2023

Alinia Criteria [ pdf 138.3 kB ] Updated 6/16/2022

Amifampridine Criteria [ pdf 121 kB ] Updated 7/19/2023

Amlodipine (NORLIQVA® and KATERZIA®) oral solution/suspension Criteria [ pdf 143.5 kB ] Added 3/13/2023

Amondys 45 Criteria [ pdf 150.9 kB ] Updated 4/14/2023

Anti-Parkinson’s Agents for “Off” Episodes [ pdf 156.6 kB ] Updated 7/28/2022

Antidepressants (Age < 6 years) PA Form [ pdf 1.4 MB ] Updated 11/28/2023

Antipsychotic (Age <6) PA Form [ pdf 1.4 MB ] Updated 10/14/2020

Antipsychotic (Age 6 to <18) PA Form [ pdf 1.9 MB ] Updated 11/28/2023

Antipsychotic Non-Preferred Criteria [ pdf 145.5 kB ] Updated 1/24/2024

Antipsychotic Polypharmacy Criteria [ pdf 383 kB ] Added 7/7/2020

Aplenzin [ pdf 300.6 kB ] New 6/5/2015

Arikayce Criteria [ pdf 117.4 kB ] Added 4/30/2021

Automated Prior Authorizations and Bypass Lists [ pdf 1.8 MB ] Updated 11/25/2024

Auvelity Criteria [ pdf 174.1 kB ] Added 6/27/2023

Benlysta Criteria [ pdf 148.8 kB ] Updated 12/29/2021

Besremi Criteria [ pdf 138 kB ] Updated 9/8/2022

Bile Salts Agents Criteria [ pdf 146.3 kB ] Added 1/7/2022

Blincyto Criteria [ pdf 70.2 kB ] Added 6/16/2022

Boniva Injection Criteria [ pdf 181.5 kB ] Updated 1/24/2024

Botulinum Criteria [ pdf 113.6 kB ] Updated 1/24/2024

Brexafemme Criteria [ pdf 114.2 kB ] Added 11/15/2022

Breyanzi Criteria [ pdf 161.6 kB ] Updated 10/14/2022

Brineura Criteria [ pdf 155 kB ] Added 1/27/2023

Brisdelle Criteria [ pdf 295.9 kB ] Updated 2/28/2018

Bronchitol Criteria [ pdf 118.3 kB ] Added 4/30/2021

Buprenorphine Agents for Pain [ pdf 75.6 kB ] Updated 11/30/2023

Butalbital Criteria [ pdf 100.9 kB ] Updated 4/22/2022

Camzyos Criteria [ pdf 178 kB ] Added 10/14/2022

Carbaglu Critieria [ pdf 168.1 kB ] Updated 9/17/2021

Carvykti Criteria [ pdf 177.1 kB ] Added 6/16/2022

Casgevy Criteria [ pdf 151.4 kB ] Added 8/14/2024

Cayston Criteria [ pdf 300.3 kB ] Updated 2/24/2015

Ceprotin Criteria [ pdf 295.1 kB ] Updated 11/16/2015

Cerdelga Criteria [ pdf 125.1 kB ] Updated 2/9/2024

Cerezyme Criteria [ pdf 137.5 kB ] Updated 6/16/2022

Chantix Criteria [ pdf 112.4 kB ] Updated 1/21/2022

Chemet Criteria [ pdf 145.7 kB ]  Updated 6/27/2023

Chorionic Gonadotropin Criteria [ pdf 194.8 kB ] Updated 11/16/2015

Cibinqo Criteria [ pdf 146 kB ] Updated 10/2/2023

CII-V Edit Override Criteria [ pdf 175.9 kB ] Updated April 4, 2024

Cinqair Criteria [ pdf 147.9 kB ] Updated 8/9/2022

Cinryze Criteria [ pdf 322 kB ] Added 4/12/2019

Cobenfy Criteria [ pdf 118 kB ]  Added 10/11/2024

Colchicine Agents Criteria [ pdf 140.3 kB ] Added 4/22/2022

Colony Stimulating Factors Form [ pdf 1.3 MB ] Updated 8/16/2023

Concomitant Drug Therapy Criteria [ pdf 364.4 kB ] Added 7/7/2020

Constipation Agents [ pdf 154.6 kB ] Updated 3/26/2024

Corlanor Criteria [ pdf 131.2 kB ] Updated 1/24/2024

Cough and Cold Antitussive Medications Criteria [ pdf 70.6 kB ] Updated 4/21/2021

Cresemba Criteria [ pdf 142.6 kB ] Added 11/13/2024​​​​​

Crysvita Criteria [ pdf 98 kB ] Updated 7/1/2024

Cubicin Criteria [ pdf 281 kB ] Updated 10/3/2019

Cyanocobalamin Criteria [ pdf 23.5 kB ] Updated 4/22/2022

Cyramza Criteria [ pdf 344.3 kB ] Updated 6/14/2019

Cytokines and CAM Antagonists Criteria [ pdf 255.8 kB ] Updated 11/13/2024

Cytogam PA Form [ pdf 1015.2 kB ] Updated 11/28/2023

Daliresp Criteria [ pdf 190.7 kB ] Added 6/27/2018

Dalvance Criteria [ pdf 75.9 kB ] Updated 12/10/2021

Daraprim Criteria [ pdf 119.1 kB ] Updated 12/29/2021

Daybue Criteria [ pdf 189.3 kB ] Updated 11/08/2023​​​​​

Diacomit Criteria [ pdf 138.3 kB ] Updated 10/14/2022

Dibenzyline Criteria [ pdf 135.9 kB ] Updated 7/7/2022

Dificid Criteria [ pdf 256.4 kB ] Updated 6/22/2022

Dojolvi Criteria [ pdf 126.9 kB ] Added 10/29/2020

Dupixent Criteria [ pdf 176.1 kB ] Updated 11/13/2024

Elfabrio Criteria [ pdf 120.8 kB ] Added 2/27/2024

Elmiron Criteria [ pdf 182 kB ] Updated 11/16/2015

Emflaza Criteria [ pdf 229.2 kB ] Updated 6/28/2019

Empaveli Criteria [ pdf 141.2 kB ] Added 9/21/2021

Enjaymo Criteria [ pdf 117 kB ]  Updated 10/2/2023

Enspryng Criteria [ pdf 143.3 kB ] Added 9/2/2020

Entadfi Criteria [ pdf 179 kB ] Added 5/5/2023

Epaned Criteria [ pdf 197.9 kB ] Updated 1/24/2024

Erwinaze and Rylaze Criteria [ pdf 142.6 kB ]  Updated 4/12/2024

Erythropoeisis Stimulating Agents Criteria [ pdf 235.4 kB ] Updated 1/24/2024

Erythropoeisis Stimulating Agents Form [ pdf 1 MB ] Updated 11/28/2023

Esbriet Criteria [ pdf 339.7 kB ] Updated 5/19/2020

Evenity Criteria [ pdf 151.1 kB ] Updated 5/8/2024

Evrysdi Criteria [ pdf 150.7 kB ] Updated 10/14/2022

Exjade Criteria [ pdf 170 kB ] Updated 10/15/2021

Exondys 51 Criteria [ pdf 152.7 kB ] Updated 3/31/2022

Exondys PA Form [ pdf 1008.8 kB ] Updated 11/28/2023

Fabhalta Criteria [ pdf 145.5 kB ] Added 2/28/2024

Fasenra Criteria [ pdf 185.5 kB ]  Updated 8/19/2024

Ferriprox Criteria [ pdf 159.8 kB ] Updated 3/11/2022

Fetzima Criteria [ pdf 338.1 kB ] Updated 6/15/2016

Filspari Criteria [ pdf 161.3 kB ] Added 1/26/2024

Filsuvez Criteria [ pdf 123.9 kB ] Added 9/19/2024

Fintepla Criteria [ pdf 122.1 kB ] Updated 6/16/2022

Firvanq Criteria [ pdf 69.9 kB ] Updated 6/16/2022

Fleqsuvy Criteria [ pdf 172.6 kB ] Added 7/8/2022

Forteo Criteria [ pdf 159.7 kB ] Updated 1/24/2024

Fuzeon PA Form [ pdf 1016 kB ] Updated 11/28/2023

Galafold Criteria [ pdf 397.5 kB ] Added 1/18/2019

Gamifant Criteria [ pdf 69.2 kB ] Added 9/25/2020

Gattex Criteria [ pdf 334 kB ] Updated 6/3/2019

Gemtesa Criteria [ pdf 121.7 kB ] Added 2/27/2024

Gimoti Criteria [ pdf 112.4 kB ] Added 8/4/2021

Givlaari Criteria [ pdf 145.7 kB ] Added 8/4/2021

H.P. Acthar Gel Criteria [ pdf 143.5 kB ] Updated 3/11/2022

Haegarda Criteria [ pdf 119 kB ] Updated 10/30/2020

Hemady Criteria [ pdf 114.1 kB ] Added 8/4/2021

Hemangeol Criteria [ pdf 173.8 kB ] Updated 1/27/2023

Hepatitis C Agents Criteria [ pdf 117.6 kB ] Updated 3/13/2023

Hepatitis C Agents Form [ pdf 1.9 MB ] Updated 11/28/2023

Hetlioz Criteria [ pdf 188.6 kB ] Updated 1/13/2022

HIV Auto PA Form [ pdf 144.1 kB ] Updated 12/7/2021

HIV Diagnosis Verification or Prophylaxis of HIV Form [ pdf 1.3 MB ] Updated 11/28/2023

Human Growth Hormone Criteria [ pdf 288.9 kB ] Updated 8/19/2024

Human Growth Hormone PA Form [ pdf 1.6 MB ] Updated 8/26/2024

Hyftor Criteria [ pdf 171.4 kB ] Added 5/2/2023

Hyperlipidemia Agents Criteria [ pdf 250.5 kB ] Updated 11/7/2024

Ibsrela Criteria [ pdf 122.6 kB ] Added 2/27/2024

iDose TR Criteria [ pdf 141.1 kB ] Added 8/19/2024

​​​​ Ileal Bile Acid Transporter Inhibitor Agents Criteria [ pdf 151 kB ] Updated 7/10/2024

Imcivree Criteria [ pdf 147.6 kB ] Added 4/30/2024

Immune Globulin Criteria [ pdf 421.8 kB ] Updated 10/11/2024

Increlex PA Form [ pdf 1.3 MB ] Updated 11/28/2023

Injectable and Intravenous Iron Agents Criteria [ pdf 174.1 kB ] Updated 7/20/2023

Isturisa Criteria [ pdf 122 kB ] Added 6/9/2021

Joenja Criteria [ pdf 132 kB ] Updated 4/9/2024

Kadcyla Criteria [ pdf 144.9 kB ] Updated 10/14/2022

Kalbitor Criteria [ pdf 224.4 kB ] Added 3/20/2020

Kalydeco Critieria [ pdf 176.2 kB ] Updated 9/9/2024

Kanuma Criteria [ pdf 69.8 kB ] Added 3/30/2022

Kapvay Critieria [ pdf 319.3 kB ] Updated 11/19/2015

Kepivance Critieria [ pdf 42.9 kB ] Updated 9/8/2022

Kerendia Criteria [ pdf 143.2 kB ] Added 12/10/2021

Kimmtrak Criteria [ pdf 135.9 kB ] Added 6/16/2022

Korlym Criteria [ pdf 115.2 kB ] Updated 7/7/2022

Krystexxa Criteria [ pdf 140 kB ] Updated 10/14/2022

Kymriah Criteria [ pdf 165.3 kB ] Updated 10/14/2022

Lacrisert Criteria [ pdf 156.7 kB ] Updated 7/7/2022

Lampit Criteria [ pdf 120.8 kB ] Updated 1/24/2024

Lamzede Criteria [ pdf 92.9 kB ] Added 1/26/2024

Leqembi Criteria [ pdf 189.3 kB ] Added 6/15/2023

Lioresal/Gablofen Criteria [ pdf 143.3 kB ] Updated 7/7/2022

Livtencity Criteria [ pdf 117.2 kB ] Added 3/30/2022

Long Acting Beta 2 Agonists Criteria [ pdf 135.5 kB ] Updated 7/9/2021

Long Acting Stimulants in Children Criteria [ pdf 114 kB ]  Updated 5/11/2023

Lucemyra Criteria [ pdf 118 kB ] Added 1/11/2021

Lumryz Criteria [ pdf 172.9 kB ] Added 1/26/2024

Lupkynis Criteria [ pdf 152.2 kB ] Added 6/9/2021

Luxturna Criteria [ pdf 378.4 kB ] Added 3/27/2018

Lybalvi Criteria [ pdf 186.9 kB ] Updated 11/15/2024​​​​​​

Lyfgenia Criteria [ pdf 151.7 kB ] Added 8/14/2024

Marinol Criteria [ pdf 180.9 kB ] Updated 6/8/2016

Methadone Criteria [ pdf 510.7 kB ] Update 3/15/2018

Miscellaneous Drug Criteria [ pdf 123 kB ] Updated 6/27/2023

Miscellaneous Pharmacy Prior Authorization Requests [ pdf 813.6 kB ] Updated 11/28/2023

Mounjaro Criteria [ pdf 142.9 kB ] Updated 4/26/2024

Mozobil Criteria [ pdf 308.1 kB ] Updated 11/6/2017

Mucopolysaccharidosis Agents Criteria [ pdf 154.7 kB ] Added 3/13/2023

Multi Source Brand Drug PA Form [ pdf 1001.6 kB ] Updated 11/28/2023

Multiple Sclerosis Oral Agents Criteria [ pdf 146.3 kB ] Updated 2/5/2024

Myalept Criteria [ pdf 119.9 kB ] Updated 4/12/2024

Myfembree Criteria [ pdf 142.9 kB ] Updated 4/13/2023

Myrbetriq Criteria [ pdf 145.1 kB ] Added 2/27/2024

Mytesi Criteria [ pdf 183.1 kB ] Added 11/20/2020

Namenda XR Criteria [ pdf 123.8 kB ] Updated 1/24/2024

Natacyn Criteria [ pdf 292.6 kB ]

Neupro Criteria [ pdf 441 kB ] Updated 11/19/2015

Nitisinone PA Form [ pdf 1.3 MB ] Updated 10/13/2020

Nucala Criteria [ pdf 166.8 kB ] Updated 8/9/2022

Nuplazid Criteria [ pdf 290.8 kB ] Updated 8/8/2018

Ocreotides & Related Agents Criteria [ pdf 159.3 kB ] Added 1/19/2022

Ofev Criteria [ pdf 140.7 kB ] Updated 7/1/2024

Off Label Use Criteria [ pdf 93.1 kB ] Updated 6/27/2023

Olpruva Criteria [ pdf 182.6 kB ] Updated 8/19/2024

Opioid PA Form [ pdf 587.6 kB ] Updated 11/28/2023

Opzelura Criteria [ pdf 144.3 kB ] Updated 9/19/2024

Oralair [ pdf 135.5 kB ] Added 2/1/2022

Oral Oncology Criteria [ pdf 496.3 kB ] Updated 11/13/2024

Oral Oncology PA Form [ pdf 1.2 MB ] Updated 11/28/2023

Oriahnn Criteria [ pdf 136.5 kB ] Added 9/21/2020

Orilissa Criteria [ pdf 324.1 kB ] Added 1/18/2019

Oritavancin Criteria [ pdf 156.1 kB ] Updated 1/27/2023

Orkambi Criteria [ pdf 158.7 kB ] Updated 5/11/2023

Orladeyo Criteria [ pdf 111.2 kB ] Added 4/2/2021

Ortikos Criteria [ pdf 134.6 kB ] Added 8/4/2021

Otrexup Criteria [ pdf 197.1 kB ] Added 7/27/2016

Overactive Bladder Agents Criteria [ pdf 74.6 kB ] Updated 3/26/2024

Oxalosis Agents Criteria [ pdf 186 kB ] Updated 7/1/2024

Oxandrin Criteria [ pdf 127.4 kB ] Updated 12/22/2016

Oxbryta Criteria [ pdf 123 kB ] Updated 8/14/2024

Palforzia Criteria [ pdf 165.5 kB ] Updated 11/12/2021

Panretin PA Form [ pdf 1.3 MB ] Updated 11/28/2023

Pheburane Criteria [ pdf 70.8 kB ]  Updated 11/14/2024​​​​​​

Phenylketonuria Treatments Criteria [ pdf 90.9 kB ] Added 3/13/2023

Pompe Disease Agents [ pdf 143.9 kB ] Added 12/10/2021

Prevymis Criteria [ pdf 149.6 kB ] Updated 1/24/2024

ProCentra Criteria [ pdf 127.2 kB ] Updated 7/18/2023

Proleukin PA Form [ pdf 1.3 MB ] Updated 11/28/2023

Prolia Criteria [ pdf 174.5 kB ] Updated 1/24/2024

Proton Pump Inhibitors [ pdf 488.3 kB ] Added 7/11/2016

Pulmonary Hypertension Agent Criteria [ pdf 168.8 kB ] Updated 11/13/2024

Pyrukynd Criteria [ pdf 141.3 kB ] Added 6/16/2022

Qalsody Criteria [ pdf 161.2 kB ] Added 1/26/2024

Qutenza Criteria [ pdf 144 kB ] Added 11/13/2024​​​​​​

Radicava/Radicava ORS Criteria [ pdf 151.1 kB ] Added 10/14/2022

Rasuvo Criteria [ pdf 197.2 kB ] Added 7/27/2016

Ravicti Criteria [ pdf 85.3 kB ] Updated 8/19/2024

Reblozyl Criteria [ pdf 379.7 kB ] Added 7/10/2020

Recorlev Criteria [ pdf 115.6 kB ] Added 6/16/2022

Rectiv Criteria [ pdf 353.2 kB ]

Regranex Criteria [ pdf 227 kB ] Updated 11/6/2018

Relyvrio Criteria [ pdf 148.1 kB ] Added 5/11/2023

Revcovi Criteria [ pdf 88.7 kB ] Added 1/7/2022

Reyvow Criteria [ pdf 135.1 kB ] Added 10/29/2021

Rezdiffra Criteria [ pdf 181.4 kB ] Added 9/19/2024

Rezurock Criteria [ pdf 115.3 kB ] Added 12/17/2021

Rinvoq ER Criteria [ pdf 127.4 kB ] Updated 11/13/2024

Ruconest Criteria [ pdf 321.4 kB ] Added 4/12/2019

Sancuso Criteria [ pdf 195.2 kB ] Updated 1/15/2015

Saphnelo Criteria [ pdf 115.9 kB ] Added 12/17/2021

Saphris Criteria [ pdf 147.5 kB ] Updated 1/24/2024

Sedative Hypnotic Criteria [ pdf 115.1 kB ] Updated 11/13/2024

Selzentry PA Form [ pdf 966.2 kB ] Updated 11/28/2023

Serostim PA Form [ pdf 1 MB ] Updated 11/28/2023

Sirturo Criteria [ pdf 120.4 kB ] Updated 9/8/2022

Skyclarys Criteria [ pdf 187.2 kB ] Updated 5/8/2024

Sodium-Glucose Co-Transporter (SGLT-2) Inhibitor Agents [ pdf 160.3 kB ] Updated 9/9/2024

Soliris Criteria [ pdf 80.6 kB ] Updated 6/10/2021

Soma PA Form [ pdf 2 MB ] Updated 2/9/2024

Spinraza Criteria [ pdf 158.2 kB ] Updated 4/23/2021

Spinraza PA Form [ pdf 965.6 kB ] Updated 11/28/2023

Spravato Criteria [ pdf 180.8 kB ] Updated 8/11/2020

Stimulants and Strattera (<6 years of age) PA Form [ pdf 936.2 kB ] Updated 11/28/2023

Sunosi Criteria [ pdf 123.6 kB ]  Updated 6/27/2023

Supprelin LA Criteria [ pdf 94.8 kB ] Updated 7/7/2022

Supprelin LA PA Form [ pdf 684.4 kB ] Updated 4/12/2024

Symdeko Criteria [ pdf 312.1 kB ] Updated 9/17/2021

Synagis Criteria [ pdf 446 kB ] Updated 4/3/2020

Synagis - All Florida Regions Combined PA Form [ pdf 1.4 MB ] Updated 11/28/2023

Synagis - Weight Change PA Form [ pdf 1007.8 kB ] Updated 11/28/2023

Synribo Criteria [ pdf 300.3 kB ] Updated 11/23/2015

Takhzyro Criteria [ pdf 119.8 kB ] Updated 1/24/2024

Tarpeyo Criteria [ pdf 121.7 kB ] Updated 9/13/2022

Tavneos Criteria [ pdf 167.8 kB ] Added 3/30/2022

Tecartus Criteria [ pdf 69.3 kB ] Updated 3/11/2022

Tepezza Criteria [ pdf 122.8 kB ] Updated 1/24/2024

Testosterone Criteria [ pdf 215.7 kB ] Updated 5/8/2024

Tezspire Criteria [ pdf 146.1 kB ] Updated 8/19/2024

Thrombopoiesis Stimulating Agents Criteria [ pdf 161.4 kB ] Updated 7/18/2023

Tolvaptan Criteria [ pdf 190.2 kB ] Updated 8/19/2024

Toujeo Criteria [ pdf 178.3 kB ] Added 8/27/2024

Transthyretin Mediated Amyloidosis Agents Criteria [ pdf 125.2 kB ] Updated 10/14/2022

Trikafta Criteria [ pdf 190.9 kB ] Updated 8/19/2024

Trudhesa Criteria [ pdf 148.2 kB ] Updated 5/6/2022

Tygacil Criteria [ pdf 78.6 kB ] Updated 7/7/2022

Tymlos Criteria [ pdf 149.8 kB ]  Updated 1/24/2024

Tzield Criteria [ pdf 152.3 kB ] Added 3/28/2023

Ultomiris Criteria [ pdf 171.1 kB ] Updated 5/8/2024

Uplizna Criteria [ pdf 146.5 kB ] Added 9/2/2020

Vecamyl Criteria [ pdf 312.4 kB ] Updated 3/14/2018

Veozah Criteria [ pdf 172.1 kB ] Added 8/27/2024

Veregen Criteria [ pdf 120.3 kB ] Updated 7/7/2022

Verkazia Criteria [ pdf 142.7 kB ] Added 11/15/2022

Verquvo Criteria [ pdf 127.8 kB ] Updated 1/24/2024

Vfend PA Form [ pdf 1 MB ] Updated 11/28/2023

Vibativ Criteria [ pdf 146.2 kB ] Updated 7/7/2022

Viberzi Criteria [ pdf 192.5 kB ] Added 4/5/2018

Viltepso Criteria [ pdf 149.8 kB ] Updated 4/14/2023

Vijoice Criteria [ pdf 117.2 kB ] Updated 7/1/2024

Vivjoa Criteria [ pdf 105.1 kB ] Added 1/29/2024

Voquezna Criteria [ pdf 115.2 kB ] Added 5/10/2024

Vowst Criteria [ pdf 159.8 kB ] Added 1/29/2024

Voxzogo Criteria [ pdf 142.7 kB ]  Updated 12/28/2023

Vpriv Criteria [ pdf 333 kB ] Added 1/18/2019

Vtama Criteria [ pdf 138.3 kB ]  Updated 5/8/2024

Vyepti Criteria [ pdf 143.2 kB ] Updated 10/29/2021

Vyjuvek Criteria [ pdf 159.4 kB ] Added 9/19/2024

Vyondys 53 Criteria [ pdf 97.3 kB ] Updated 3/31/2022

Vyvgart Criteria [ pdf 117.7 kB ] Added 3/30/2022

Wakix Criteria [ pdf 142.4 kB ] Updated 6/27/2023

Xenazine Criteria [ pdf 213.1 kB ] Updated 7/16/2018

Xenpozyme Criteria [ pdf 128.8 kB ] Added 11/15/2022

Xermelo Criteria [ pdf 247.4 kB ] Added 12/21/2017

Xgeva Criteria [ pdf 146.8 kB ] Updated 4/15/2024

Xiaflex Criteria [ pdf 185.4 kB ] Added 6/16/2022

Xifaxan Criteria [ pdf 358.7 kB ] Updated 11/23/2015

Xphozah Criteria [ pdf 121.3 kB ] Added 5/10/2024

Xolair Criteria [ pdf 171.9 kB ] Updated 9/19/2024

Xopenex Criteria [ pdf 38.1 kB ] Updated 2/9/2024

Xyrem Criteria [ pdf 163.2 kB ] Updated 11/24/2020

Xywav Criteria [ pdf 137.3 kB ] Updated 10/23/2024

Ycanth Criteria [ pdf 202.4 kB ] Added 5/10/2024

Yescarta Criteria [ pdf 71.6 kB ] Updated 6/16/2022

Zavzpret Criteria [ pdf 156.2 kB ] Added 2/9/2024

Zeposia Criteria [ pdf 146.9 kB ] Updated 4/5/2023​​​​​​

Zokinvy Criteria [ pdf 146.6 kB ] Added 8/4/2021

Zolgensma Criteria [ pdf 152 kB ] Updated 1/24/2024

Zortress Criteria [ pdf 83.1 kB ] Updated 9/8/2022

Zoryve Criteria [ pdf 146.6 kB ] Added 5/10/2024

Ztalmy Criteria [ pdf 154.3 kB ] Added 1/29/2024

Zulresso Criteria [ pdf 145.7 kB ] Updated 10/14/2022

Zurzuvae Criteria [ pdf 156.1 kB ] Added 7/2/2024

Zyprexa Relprevv [ pdf 170.9 kB ] Updated 1/24/2024